NEVROLIPON MIP caps. 600 mg. 30 caps

NEVROLIPON   MIP caps. 600 mg. 30 caps
€ 49.00
Add to Cart
Tioktevata acid is produced by the body substance that favorably affect impaired degradation of sugars in diabetics. Moreover tioktevata acid possesses antioxidant properties.

NEVROLIPON - MIP caps. 600 mg. 30 caps
 

Composition of medicine:

1 capsule contains:
Drug - Thioctic acid 600 mg
Other ingredients: gelatin, sorbitol, glycerol, colors E171/E123
 

Pharmacological action:

 
Tioktevata acid is produced by the body substance that favorably affect impaired degradation of sugars in diabetics. Moreover tioktevata acid possesses antioxidant properties.
 

Indications:

 
Unpleasant sensations in diabetes induced by multiple nerve damage.
 

Contraindications:

 
Nevrolipon MIP-600 should not be taken for a known hypersensitivity to tiokteva acid.
 

Pregnancy and lactation:

 
From previously published results for reproductive toxicity no evidence of impaired fetal activity.
 
Since there is no adequate experience proving the safety of the drug during pregnancy, after its occurrence, its application should be limited to the assessment of drugs.
 
Since no data on the drug transfer into breast milk, you should avoid its use during lactation.
 
Adverse reactions:
 
In isolated cases of allergic skin reactions. Based on the improved glucose tolerance in some cases it may be a fall in blood sugar levels.
  
Dosage, duration of treatment, and method of administration:
 
If your doctor has told you otherwise, take one capsule daily. Take Nevrolipon MIP-fasting unchewed with sufficient liquid. Take it half an hour before breakfast.
 
In severe discomfort in the beginning parenterialna recommended therapy.

Warning:

 During treatment should strictly abstain from alcohol, because alcohol and its metabolites weaken the therapeutic action of MIP-Nevrolipon.
€ 49.00
Add to Cart
Close